• OPEN AN ACCOUNT
Indian Indices
Sensex
84,961.14 -102.20
( -0.12%)
Global Indices
Nasdaq
49,481.66 483.47
(0.99%)
Dow Jones
6,965.42 42.37
(0.61%)
Hang Seng
51,924.52 -593.56
(-1.13%)
Nikkei 225
10,039.39 -83.34
(-0.82%)
Forex
USD-INR
90.21 0.17
(0.19%)
EUR-INR
105.52 0.01
(0.01%)
GBP-INR
121.54 0.38
(0.31%)
JPY-INR
0.58 0.00
(0.26%)

EQUITY - MARKET SCREENER

Alivus Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543322
INE03Q201024
245.7876662
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALIVUS
20.99
11131.49
EPS(TTM)
Face Value()
Div & Yield %
43.23
2
0.55
 

KIOCL reports standalone net loss of Rs 17.16 crore in the September 2025 quarter
Nov 14,2025
Net Loss of KIOCL reported to Rs 17.16 crore in the quarter ended September 2025 as against net loss of Rs 69.21 crore during the previous quarter ended September 2024. Sales rose 798.74% to Rs 142.54 crore in the quarter ended September 2025 as against Rs 15.86 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales142.5415.86 799
OPM %-15.15-424.02 -
PBDT-7.31-59.79 88
PBT-17.15-69.72 75
NP-17.16-69.21 75